Home LiteratureArticle Details
PMID: 15388847 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.

Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y

Abstract

Posttranslational modification by the ubiquitin homologue, small ubiquitin-like modifier 1 (SUMO-1), has been established as an important regulatory mechanism. However, in most cases it is not clear how sumoylation regulates various cellular functions. Emerging evidence suggests that sumoylation may play a general role in regulating protein-protein interactions, as shown in RanBP2/Nup358 and RanGAP1 interaction. In this study, we have defined an amino acid sequence motif that binds SUMO. This motif, V/I-X-V/I-V/I, was identified by NMR spectroscopic characterization of interactions among SUMO-1 and peptides derived from proteins that are known to bind SUMO or sumoylated proteins. This motif binds all SUMO paralogues (SUMO-1-3). Using site-directed mutagenesis, we also show that this SUMO-binding motif in RanBP2/Nup358 is responsible for the interaction between RanBP2/Nup358 and sumoylated RanGAP1. The SUMO-binding motif exists in nearly all proteins known to be involved in SUMO-dependent processes, suggesting its general role in sumoylation-dependent cellular functions.

MeSH Terms
Amino Acid Motifs Amino Acid Sequence Binding Sites Consensus Sequence GTPase-Activating Proteins/chemistry,metabolism Humans In Vitro Techniques Macromolecular Substances Models, Molecular Molecular Chaperones Molecular Sequence Data Mutagenesis, Site-Directed Nuclear Magnetic Resonance, Biomolecular Nuclear Pore Complex Proteins/chemistry,metabolism Protein Processing, Post-Translational Recombinant Proteins/chemistry,genetics,metabolism SUMO-1 Protein/chemistry,metabolism Small Ubiquitin-Related Modifier Proteins/chemistry,metabolism Static Electricity
Chemicals
GTPase-Activating Proteins Macromolecular Substances Molecular Chaperones Nuclear Pore Complex Proteins RANGAP1 protein, human Recombinant Proteins SUMO-1 Protein SUMO2 protein, human Small Ubiquitin-Related Modifier Proteins ran-binding protein 2
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Song Jing
Division of Immunology, Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010, USA.
Durrin Linda K
Wilkinson Thomas A
Krontiris Theodore G
Chen Yuan
References (34)
34 references, click to expand
  1. SUMO-1 modification activates the transcriptional response of p53.
    EMBO J. 1999 Nov 15;18(22):6455-61 PMID: 10562557
  2. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription.
    J Biol Chem. 1999 Jul 2;274(27):19441-6 PMID: 10383460
  3. Role of SUMO-1-modified PML in nuclear body formation.
    Blood. 2000 May 1;95(9):2748-52 PMID: 10779416
  4. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.
    J Biol Chem. 2000 Nov 17;275(46):36316-23 PMID: 10961991
  5. Protein modification by SUMO.
    Trends Biochem Sci. 2001 May;26(5):332-3 PMID: 11343927
  6. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases.
    Genes Dev. 2001 Dec 1;15(23):3053-8 PMID: 11731472
  7. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.
    Genes Dev. 2001 Dec 1;15(23):3088-103 PMID: 11731474
  8. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
    Cell. 2002 Jan 11;108(1):109-20 PMID: 11792325
  9. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.
    J Biol Chem. 2002 Feb 15;277(7):4755-63 PMID: 11709548
  10. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
    Cell. 2002 Feb 8;108(3):345-56 PMID: 11853669
  11. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects.
    Cell. 2002 Feb 22;108(4):489-500 PMID: 11909520
  12. Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in receptor endocytosis.
    Nat Cell Biol. 2002 May;4(5):389-93 PMID: 11988742
  13. Identification of a substrate recognition site on Ubc9.
    J Biol Chem. 2002 Jun 14;277(24):21740-8 PMID: 11877416
  14. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1.
    J Biol Chem. 2002 Aug 16;277(33):30283-8 PMID: 12060666
  15. Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1.
    J Biol Chem. 2003 Apr 4;278(14):12335-43 PMID: 12529333
  16. P300 transcriptional repression is mediated by SUMO modification.
    Mol Cell. 2003 Apr;11(4):1043-54 PMID: 12718889
  17. Solution structure of a CUE-ubiquitin complex reveals a conserved mode of ubiquitin binding.
    Cell. 2003 May 30;113(5):621-30 PMID: 12787503
  18. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Biochemistry. 2003 Aug 26;42(33):9959-69 PMID: 12924945
  19. Solution structure of Vps27 UIM-ubiquitin complex important for endosomal sorting and receptor downregulation.
    EMBO J. 2003 Sep 15;22(18):4597-606 PMID: 12970172
  20. Nuclear and unclear functions of SUMO.
    Nat Rev Mol Cell Biol. 2003 Sep;4(9):690-9 PMID: 14506472
  21. SUMO promotes HDAC-mediated transcriptional repression.
    Mol Cell. 2004 Feb 27;13(4):611-7 PMID: 14992729
  22. SUMO: a regulator of gene expression and genome integrity.
    Oncogene. 2004 Mar 15;23(11):1998-2008 PMID: 15021887
  23. SUMO modification of Huntingtin and Huntington's disease pathology.
    Science. 2004 Apr 2;304(5667):100-4 PMID: 15064418
  24. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis.
    J Immunol. 1990 Dec 15;145(12):4338-47 PMID: 2258622
  25. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML.
    Cell. 1991 Aug 23;66(4):663-74 PMID: 1652368
  26. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation.
    Biochemistry. 1994 May 17;33(19):5984-6003 PMID: 7514039
  27. Multidimensional heteronuclear nuclear magnetic resonance of proteins.
    Methods Enzymol. 1994;239:349-63 PMID: 7830590
  28. The CBP co-activator is a histone acetyltransferase.
    Nature. 1996 Dec 19-26;384(6610):641-3 PMID: 8967953
  29. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2.
    Cell. 1997 Jan 10;88(1):97-107 PMID: 9019411
  30. Daxx, a novel Fas-binding protein that activates JNK and apoptosis.
    Cell. 1997 Jun 27;89(7):1067-76 PMID: 9215629
  31. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex.
    J Cell Biol. 1998 Feb 9;140(3):499-509 PMID: 9456312
  32. Structure determination of the small ubiquitin-related modifier SUMO-1.
    J Mol Biol. 1998 Jul 10;280(2):275-86 PMID: 9654451
  33. The binding interface between an E2 (UBC9) and a ubiquitin homologue (UBL1).
    J Biol Chem. 1999 Jun 11;274(24):16979-87 PMID: 10358047
  34. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.
    J Biol Chem. 2000 Mar 3;275(9):6252-8 PMID: 10692421
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2004-10-05
Epub
2004-00-23
Pages
14373-8
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC521952
Subset
IM
Grants
NCI NIH HHS · R01 CA094595 · United States
NIGMS NIH HHS · R01 GM059887 · United States
NCI NIH HHS · CA 94595 · United States
NIGMS NIH HHS · GM 59887 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]